Articles from Worldwide Biotech (May 1, 2002)

1-5 out of 5 article(s)

Title	Author	Type	Words
ALLIANCE PLANS EUROPEAN PHASE 3 STUDY FOR OXYGENT.			472
FDA CLEARS THROMBOLYTIC DRUG FOR PHASE II CLINICAL TRIAL.			981
GILEAD SUBMITS MAA TO EMEA FOR ADEFOVIR DIPIVOXIL 10 MG.			751
MPM CAPITAL LEADS EUR22 MILLION FINANCING OF BIOXELL.			534
ORTEC SUCCESSFULY DEFENDS EUROPEAN PATENT ON ORCEL.			359

Publications by Name	Publications by Date	Authors	Literature
A-D E-O P-T U-Z	17 74 75 78 80 82 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z